Updated: August 9, 2007
A Vaccine Trial Is Announced for CLL Patients
Finally It's Our Turn ...
Genitope Corp. has announced a clinical trial of their MyVax proprietary vaccine technology for untreated, early stage CLL patients. We examine this promising technology and the structure of the Genitope clinical trial in our new article, A Vaccine Trial for CLL Patients.
An Idiotype Vaccine Trial for CLL?
Genitope Corporation May Try Its Vaccine in CLL
In January 2004 Genitope Corp. held an Advocacy Summit meeting which we were invited to attend. Genitope's proprietary MyVax technology has shown good results in NHL and holds promise in CLL, in spite of certain technical difficulties. This article provides an introduction to the vaccine technology and discusses the prospects for its application in CLL. Read our comments in An Idiotype Vaccine for CLL?
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright © 2002-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.